Literature DB >> 11205369

Evoked potentials in monitoring multiple sclerosis.

L Leocani1, S Medaglini, G Comi.   

Abstract

The usefulness of evoked potentials (EPs) in the diagnosis of multiple sclerosis is limited by its relatively low sensitivity to subclinical lesions. However, they are still a good tool to assess the integrity of afferent and efferent pathways and to quantify the severity of white matter involvement. Transversal and longitudinal studies have demonstrated good correlation between EP abnormalities and disability, suggesting that multimodal evoked potentials could be useful in monitoring the disease evolution in single patients and as surrogate end points in clinical trials.

Entities:  

Mesh:

Year:  2000        PMID: 11205369     DOI: 10.1007/s100720070032

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

Review 1.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

Review 2.  Strategies for achieving and monitoring myelin repair.

Authors:  Claire Rice; Neil Scolding
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

3.  Sensory evoked potentials to predict short-term progression of disability in multiple sclerosis.

Authors:  N Margaritella; L Mendozzi; M Garegnani; E Colicino; E Gilardi; L Deleonardis; F Tronci; L Pugnetti
Journal:  Neurol Sci       Date:  2011-11-27       Impact factor: 3.307

4.  Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.

Authors:  Claire M Rice; David I Marks; Yoav Ben-Shlomo; Nikos Evangelou; Paul S Morgan; Chris Metcalfe; Peter Walsh; Nick M Kane; Martin G Guttridge; Gail Miflin; Stuart Blackmore; Pamela Sarkar; Juliana Redondo; Denise Owen; David A Cottrell; Alastair Wilkins; Neil J Scolding
Journal:  Trials       Date:  2015-10-14       Impact factor: 2.279

5.  Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II).

Authors:  Claire M Rice; David I Marks; Peter Walsh; Nick M Kane; Martin G Guttridge; Juliana Redondo; Pamela Sarkar; Denise Owen; Alastair Wilkins; Neil J Scolding
Journal:  BMJ Open       Date:  2015-09-11       Impact factor: 2.692

6.  Visual Evoked Potential and Magnetic Resonance Imaging are More Effective Markers of Multiple Sclerosis Progression than Laser Polarimetry with Variable Corneal Compensation.

Authors:  Ema Kantorová; Peter Ziak; Egon Kurča; Mária Koyšová; Mária Hladká; Kamil Zeleňák; Jozef Michalik
Journal:  Front Hum Neurosci       Date:  2014-01-22       Impact factor: 3.169

7.  Frontoparietal connectivity correlates with working memory performance in multiple sclerosis.

Authors:  Alejandra Figueroa-Vargas; Claudia Cárcamo; Rodrigo Henríquez-Ch; Francisco Zamorano; Ethel Ciampi; Reinaldo Uribe-San-Martin; Macarena Vásquez; Francisco Aboitiz; Pablo Billeke
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.